Pinho J D, Rivas P M S, Mendes M B P, Soares R E P, Costa G C, Nascimento F R F, Paiva M F L, Aquino D M C, Figueireido I A, Santos A M, Pereira S R F
Laboratório de Genética e Biologia Molecular, Departamento de Biologia, Universidade Federal do Maranhão, São Luís, MA, Brasil.
Laboratório de Imunofisiologia, Departamento de Patologia, Universidade Federal do Maranhão, São Luís, MA, Brasil.
Genet Mol Res. 2015 Nov 19;14(4):14479-87. doi: 10.4238/2015.November.18.10.
Leprosy is a highly infectious disease endemic to underdeveloped countries. In Maranhão State, Northeastern Brazil, the hyperendemic rate of 56.11 cases/100,000 inhabitants increased the necessity of better understanding the epidemiological profile of this population, particularly regarding efficient methods for evaluating individuals residing with diagnosed patients to understand disease transmission and the risk of infection. In this study, we examined the percentage of contacts with positive indices for Mycobacterium leprae DNA and phenol-glycolipid-1 antigen (PGL-1). PGL-1 was analyzed by an enzyme-linked immunosorbent assay, the ML-Flow test, and polymerase chain reaction of oral and nasal secretions of 808 leprosy contacts from Maranhão. PGL-1 was detected in 14.0% of patients and differed by operational classification of the index case (P < 0.05). Seropositive results of ML-Flow were 15.0% and identified individuals with and without Bacillus Calmette-Guérin vaccine scars. Molecular diagnosis detected M. leprae DNA in 5.6% of oral samples and 4.6% of nasal tissues, and 87% of subjects resided with high bacillary load patients. This study reinforces the efficacy of combining molecular and serological techniques to identify potential bacillus carriers in the asymptomatic stage of infection, such as in household contacts, highlighting the importance of these meth-ods for monitoring hyperendemic populations.
麻风病是一种在不发达国家流行的高度传染性疾病。在巴西东北部的马拉尼昂州,每10万居民中56.11例的高流行率增加了更好地了解该人群流行病学特征的必要性,特别是关于评估与确诊患者同住的个体以了解疾病传播和感染风险的有效方法。在本研究中,我们检测了麻风分枝杆菌DNA和酚糖脂-1抗原(PGL-1)阳性指标的接触者百分比。通过酶联免疫吸附测定、ML-Flow试验以及对来自马拉尼昂的808名麻风病接触者的口腔和鼻腔分泌物进行聚合酶链反应来分析PGL-1。在14.0%的患者中检测到PGL-1,并且根据索引病例的操作分类有所不同(P<0.05)。ML-Flow的血清阳性结果为15.0%,并识别出有和没有卡介苗疫苗疤痕的个体。分子诊断在5.6%的口腔样本和4.6%的鼻组织中检测到麻风分枝杆菌DNA,并且87%的受试者与高菌量患者同住。本研究强化了结合分子和血清学技术来识别感染无症状阶段潜在杆菌携带者(如家庭接触者)的有效性,突出了这些方法对监测高流行人群的重要性。